Table 2 Summary of radiologic and pathologic characteristics of the two cohorts of patients included in this study. *4 patients had PI-RADS 1 scores, and 1 patient had PI-RADS 2 scores. **27 patients had PI-RADS 1 scores, and 4 patients had PI-RADS 2 scores. †Part of a prospective research study without clinical evaluation by a radiologist.
Cohort 1 (n = 46) | ||
---|---|---|
Available pathology | Systematic biopsy only | 6 |
Targeted Biopsy Only | 0 | |
Systematic and targeted biopsy | 20 | |
Prostatectomy | 15 | |
No biopsy or prostatectomy* | 5 | |
PI-RADS | 1 | 9 |
2 | 2 | |
3 | 10 | |
4 | 10 | |
5 | 15 | |
Not available | 0 | |
Gleason grade group | Benign | 17 |
1 | 2 | |
2 | 9 | |
3 | 8 | |
4 | 1 | |
5 | 4 |
Cohort 2 (n = 195) | ||
---|---|---|
Available pathology | Systematic biopsy only | 44 |
Targeted Biopsy Only | 5 | |
Systematic and targeted biopsy | 60 | |
Prostatectomy | 28 | |
No biopsy or prostatectomy** | 31 | |
PI-RADS | 1 | 66 |
2 | 10 | |
3 | 18 | |
4 | 36 | |
5 | 27 | |
Not available† | 38 | |
Gleason grade group | Benign | 38 |
1 | 30 | |
2 | 40 | |
3 | 32 | |
4 | 7 | |
5 | 17 |